IL4 and Alzheimer disease: Interestingly, the elevated levels of IL-4 in the dorsal skin lesions of mice with AD were significantly reduced by treatment with Dex-ADT, but not with Dex or Dex-TBZ, although the animals treated with the latter showed significantly lower concentrations than those measured in the Dex-treated group.